Indian Pharmacopoeia Commission
Indian Pharmacopoeia Commission (IPC) is an autonomous institution of the Ministry of Health and Family Welfare, Government of India. It is responsible for setting standards for drugs, pharmaceuticals and healthcare devices and technologies in India.
History[edit | edit source]
The IPC was established in 1948 following the recommendations of the Drug Enquiry Committee formed by the Government of India. The first edition of the Indian Pharmacopoeia was published in 1955.
Function[edit | edit source]
The IPC is responsible for the publication of the Indian Pharmacopoeia (IP), which is a legally recognized book of standards for drugs and pharmaceuticals in India. The IP is published in English and is revised periodically to include new drugs and to revise existing standards.
The IPC also publishes the National Formulary of India (NFI), which is a companion volume to the IP and provides a guide to healthcare professionals on the use of drugs and medicines.
Structure[edit | edit source]
The IPC is governed by a governing body which includes representatives from the Ministry of Health and Family Welfare, the Drug Controller General of India, the Indian Council of Medical Research, the Pharmacy Council of India, and the All India Drugs Control Officers' Confederation.
The IPC has a secretariat which is responsible for the day-to-day operations of the commission. The secretariat is headed by a Secretary-cum-Scientific Director.
Activities[edit | edit source]
The IPC conducts various activities related to the standardization of drugs and pharmaceuticals in India. These include:
- Publication of the Indian Pharmacopoeia and the National Formulary of India
- Conducting post-market surveillance of drugs and pharmaceuticals
- Providing training and education on the use of the IP and the NFI
- Conducting research on drug standardization and quality control
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
